AR & AGE-RAGE IN AGING: IMPACT ON ENDOTHELIAL AND VASCULAR STRESS
增强现实
基本信息
- 批准号:8042640
- 负责人:
- 金额:$ 21.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:1,2-diacylglycerol3-deoxyglucosoneAddressAdenovirusesAdvanced Glycosylation End ProductsAgeAgingAnimalsAntigensAtherosclerosisAutomobile DrivingBiochemicalBlood VesselsC57BL/6 MouseCCAAT-Enhancer-Binding ProteinsCardiac MyocytesCardiovascular DiseasesCardiovascular systemCell AgingCell DeathCellsCellular StressCessation of lifeCollaborationsComplementCoronary arteryCoupledCritiquesDataDevelopmentDiabetes MellitusDiglyceridesDiseaseDominant-Negative MutationDoseEmployee StrikesEndothelial CellsEndotheliumEnzymesFunctional disorderGenerationsGeneticGenetic ModelsGrantHeartHistocompatibility TestingHumanHydrogen PeroxideHypertensionHypoxiaInbred F344 RatsInflammationInflammation MediatorsInflammatoryInjuryIschemiaL-Iditol 2-DehydrogenaseLinkMediatingMediator of activation proteinMessenger RNAMitochondriaModelingMusMuscle CellsNF-kappa BOrganismOxidative StressOxidoreductasePPETPathway interactionsPhenotypePrincipal InvestigatorProcessProductionProtein Kinase CProteinsPublishingPyruvaldehydeRattusReactive Oxygen SpeciesReagentRecruitment ActivityReperfusion InjuryReperfusion TherapyResourcesRoleSignal TransductionSmall Interfering RNAStressTailTechniquesTestingTimeTranscription Factor AP-1Transcriptional RegulationTransgenic OrganismsUp-RegulationVascular Endothelial CellVentricularWild Type MouseWorkage relatedagedbasebiological adaptation to stresscaspase-9cell agecell injurycell typeemergency service responderhuman subjectin vitro Modelinhibitor/antagonistinsightjuvenile animalmiddle agemutantnovelpolyolproendothelin 1programspromoterreceptorreceptor for advanced glycation endproductsresearch studyresponsetranscription factorvascular endothelial dysfunctionvascular inflammation
项目摘要
Aging in human subjects is accompanied by the inevitable development of cardiovascular and endothelial
dysfunction, which, over time, especially as co-incident and superimposed aging-related disorders mount,
leads to a heightened vulnerability to ischemia/reperfusion (I/R) stress. In response to the critique, we have
developed and focused this project on two key components of aging cardiovasculature that prime the aged
organism for amplified injury, both innately, and upon I/R. These studies are tightly coupled to Projects 1 & 2
of this Program. First, basal degrees of inflammation increase in aged vasculature, particularly in aged
endothelial cells (EC). Second, innate cardiomyocyte dysfunction develops in aging. Mitochondria become
defective in cardiomyocytes as they age and increase generation of reactive oxygen species (ROS), thereby
impairing ATP generation. Such fundamental injury phenomena promote conditions for enhanced cell death
- especially in I/R. Thus, in both EC and cardiomyocytes retrieved from aged animals, identification of the
precise signal transduction and transcriptional regulation mechanisms underlying these findings is essential
in identifying novel targets to suppress adverse cardiovascular aging and diminish the amplified vulnerability
to I/R stress. We will probe the hypothesis that increased activity of the polyol enzyme AR in aging drives
mechanisms that enhance generation of AGE, thereby recruiting RAGE and consequent signal transduction
in EC and cardiomyocytes; mechanisms which we predict are linked to cardiovascular dysfunction. We
propose that when aged organisms are exposed to superimposed I/R stress in the heart, increased AR and
AGE-RAGE signaling amplify production of inflammatory and stress mediators that exaggerate injury in the
aged heart. In a manner highly synergistic with Projects 1&2 (intact heart), isolated EC and cardiomyocytes
from aged animals will be used to probe the signal transduction and transcription factor mechanisms that
regulate basal and I/R stress in the aged heart. Project 3 shares mouse/rat models with Projects 1 and 2.
Project 3 will utilize all three Cores of the Program Project during all five years of the grant.
人类的衰老不可避免地伴随着心血管和内皮细胞的发展
功能障碍,随着时间的推移,特别是随着同时发生和叠加的与衰老相关的疾病的增加,
导致更容易遭受缺血/再灌注(I/R)应激。为了回应批评,我们
该项目开发并重点关注衰老心血管系统的两个关键组成部分,为老年人做好准备
生物体会产生先天性和 I/R 后的放大损伤。这些研究与项目 1 和 2 紧密结合
本计划的。首先,老年脉管系统的基础炎症程度增加,尤其是老年人
内皮细胞(EC)。其次,先天性心肌细胞功能障碍随着衰老而发生。线粒体成为
随着年龄的增长,心肌细胞会出现缺陷并增加活性氧(ROS)的产生,从而
损害 ATP 生成。这种基本的损伤现象促进了细胞死亡的增加
- 特别是在 I/R 方面。因此,在从老年动物中获取的 EC 和心肌细胞中,鉴定出
这些发现背后的精确信号转导和转录调控机制至关重要
确定新的目标来抑制不利的心血管衰老并减少放大的脆弱性
I/R 压力。我们将探讨多元醇酶 AR 活性增加促进衰老的假设
增强 AGE 生成的机制,从而募集 RAGE 和随后的信号转导
在 EC 和心肌细胞中;我们预测的机制与心血管功能障碍有关。我们
提出当衰老的生物体暴露于心脏中叠加的 I/R 应激时,AR 和
AGE-RAGE 信号放大炎症和应激介质的产生,从而加剧损伤
年老的心。与项目 1 和 2(完整心脏)、分离的 EC 和心肌细胞高度协同
来自老年动物的信号将被用于探测信号转导和转录因子机制
调节老年心脏的基础压力和 I/R 压力。项目 3 与项目 1 和 2 共享小鼠/大鼠模型。
项目 3 将在拨款的五年内利用该计划项目的所有三个核心。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SHI FANG YAN其他文献
SHI FANG YAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SHI FANG YAN', 18)}}的其他基金
RAGE, mitochondria, and tau pathology in AD
AD 中的 RAGE、线粒体和 tau 病理学
- 批准号:
10532703 - 财政年份:2019
- 资助金额:
$ 21.31万 - 项目类别:
RAGE, mitochondria, and tau pathology in AD
AD 中的 RAGE、线粒体和 tau 病理学
- 批准号:
10320076 - 财政年份:2019
- 资助金额:
$ 21.31万 - 项目类别:
PINK1 signaling and synaptic mitochondria integrity in AD
AD 中的 PINK1 信号传导和突触线粒体完整性
- 批准号:
10091121 - 财政年份:2018
- 资助金额:
$ 21.31万 - 项目类别:
Egr-1, PKC Beta, Signalling and Atherosclerosis
Egr-1、PKC Beta、信号传导和动脉粥样硬化
- 批准号:
7162602 - 财政年份:2005
- 资助金额:
$ 21.31万 - 项目类别:
Egr-1, PKC Beta, Signalling and Atherosclerosis
Egr-1、PKC Beta、信号传导和动脉粥样硬化
- 批准号:
7330488 - 财政年份:2005
- 资助金额:
$ 21.31万 - 项目类别:
Egr-1, PKC Beta, Signalling and Atherosclerosis
Egr-1、PKC Beta、信号传导和动脉粥样硬化
- 批准号:
7006966 - 财政年份:2005
- 资助金额:
$ 21.31万 - 项目类别:
Egr-1, PKC Beta, Signalling and Atherosclerosis
Egr-1、PKC Beta、信号传导和动脉粥样硬化
- 批准号:
6867116 - 财政年份:2005
- 资助金额:
$ 21.31万 - 项目类别:
Egr-1, PKC Beta, Signalling and Atherosclerosis
Egr-1、PKC Beta、信号传导和动脉粥样硬化
- 批准号:
7568212 - 财政年份:2005
- 资助金额:
$ 21.31万 - 项目类别:
Early Growth Response-1 (Egr-1), PKC Beta and Restenosis
早期生长反应-1 (Egr-1)、PKC Beta 和再狭窄
- 批准号:
7078584 - 财政年份:2004
- 资助金额:
$ 21.31万 - 项目类别:
Early Growth Response-1 (Egr-1), PKC Beta and Restenosis
早期生长反应-1 (Egr-1)、PKC Beta 和再狭窄
- 批准号:
6894666 - 财政年份:2004
- 资助金额:
$ 21.31万 - 项目类别: